Hyperkalaemia · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor blockers (ARBs) leads to higher hyperkalaemia compared with placebo or no treatment (high certainty).
1 finding from 1 review
All‐cause mortality (RR) · patients with chronic heart failure with preserved ejection fraction
Angiotensin receptor blockers (ARBs) showed no clear difference in all‐cause mortality (RR) compared with placebo or no treatment (high certainty).
1 finding from 1 review
Quality of life (MLHFQ): from 0 to 105 · patients with chronic heart failure with preserved ejection fraction
1 finding from 1 review
Total mortality · people with primary hypertension
All angiotensin converting enzyme (ACE) inhibitors showed no clear difference in total mortality compared with all angiotensin receptor blockers (ARBs) (moderate certainty).
1 finding from 1 review
Cardiovascular events · people with primary hypertension
All angiotensin converting enzyme (ACE) inhibitors showed no clear difference in total cardiovascular events compared with all angiotensin receptor blockers (ARBs) (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with primary hypertension
All angiotensin converting enzyme (ACE) inhibitors leads to lower withdrawal due to adverse effects compared with all angiotensin receptor blockers (ARBs) (high certainty).
1 finding from 1 review
All‐cause mortality · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Risk of acute myocardial ischaemia · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes risk of acute myocardial ischaemia compared with placebo (very low certainty).
1 finding from 1 review
Congestive heart failure · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review
Hypotension · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes hypotension compared with placebo (very low certainty).
1 finding from 1 review
Rate of perioperative cerebrovascular complications · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
It is very uncertain whether ACEIs or ARBs changes rate of perioperative cerebrovascular complications compared with placebo (very low certainty).
1 finding from 1 review
Length of hospital stay · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review
Treatment related adverse events · Patients undergoing any type of surgery under general anaesthesia receiving ACEIs or ARBs perioperatively
1 finding from 1 review